GL1X · GenesisL1 explorer

MolNFT v1 · #123896 · protein

Human P-cadherin EC12 with scfv TSP11 bound

5JYM · Cadherin-3: “Human P-cadherin EC12 with scfv TSP11 bound”. X-ray diffraction, 1 ligand (CA), 7 pockets (best druggability 0.60). MolNFT v1 #123896 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5JYM
Type
protein
Length
874 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cadherin-3; Antibody scfv TSP11
UniProt
P22223
Ligands
CA
Pockets
7 · best druggability 0.60

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CCadherin-3protein2133% helix, 45% strandP22223
BAntibody scfv TSP11protein2258% helix, 47% strand—
DAntibody scfv TSP11protein2238% helix, 47% strand—

Ligands and binding sites

  • CA · Calcium ion · metal · 8 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11970.600.8134empty
2940.490.8117empty
3860.430.7915empty
4620.370.7919empty
5830.310.7323empty

Interfaces

4 interfaces between chains.

  • C–D · 900 Ų buried · 10 hydrogen bonds · protein-protein
  • A–B · 879 Ų buried · 12 hydrogen bonds · protein-protein
  • A–C · 860 Ų buried · 12 hydrogen bonds · protein-protein
  • B–C · 12 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 5JYM · Human P-cadherin EC12 with scFv TSP11 bound · the same entry in another collection · chain A against A, TM-score 1.00
  • P22223 · AlphaFold monomer V2.0 prediction for cadherin-3 (P22223) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.